Navigation Links
$3.35 Million Awarded in First Transvaginal Mesh Trial Verdict: Prompts McDonaldWorley.com Support Expansion
Date:2/26/2013

Houston, TX (PRWEB) February 26, 2013

The resulting verdict in the nations first pelvic mesh trial has prompted national law firm McDonaldWorley.com to expand the free legal reviews being provided to women who suffered complications. Attorneys with the firm emboldened by the $3.35 million compensation awarded for her past and future pain and suffering, medical costs and lost wages feel claims are strong for women who suffered problems (Gross v. Gynecare Inc., Atl-L-6966-10).

In a 7-2 vote a New Jersey state jury has dealt a blow to manufacturer Johnson & Johnson and its subsidiary in the first case to go to trial.

The jury in the landmark Atlantic City Superior Court case decided Feb. 25, according to HarrisMartin.com, found that the implanting surgeon for the plaintiff, Linda Gross, did not adequately warn of the risks associated with implanting the mesh and that the device was the proximate cause of injury. The judge is conducting a hearing to determine whether she will allow an award for punitive damages.

"The verdict signals to other women that suffered problems that they are not alone, that their needs will not be ignored. It's vital women contact us now to get their questions answered," stated Michelle R. Eddington, lead attorney with the firm.

In addition to helping people understand their legal options, the firm can help victims get funding for revision surgery to remove and repair damage caused if they don't have insurance or other means to pay for the surgery. Women are encouraged to ask for more information about financing options for corrective surgery.

The use of synthetic mesh for repair surgeries has been under scrutiny over the last three years. The FDA, having receiving thousands of reports of adverse effects, issued a health advisory warning in October 2008 to physicians considering transvaginal repair surgeries for their patients.

Dr. Margolis was quoted recently in CommonHealth.org as telling the FDA advisory panel that the use of these implants, "defies core surgical doctrines." and further mesh used in tissue repair procedures has been associated with a number of serious risks including wandering, erosion, infection, pain and perforations.

"Women should know that they are not alone, and that we are standing-by ready to ensure their needs are not ignored," added Ms. Eddington.

About McDonaldWorley.com:
Case evaluations are completely secure, 100% confidential, and being offered for women who have had surgical mesh surgery or family members.

To get information and answers from a real lawyer, click here: http://www.mcdonaldworley.com/transvaginal-mesh-lawyer.htm

Read the full story at http://www.prweb.com/releases/2013/2/prweb10467889.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NYU Langone Medical Center receives $17 million gift from the Steven A. and Alexandra M. Cohen Foundation
2. NIH awards $12.4 million grant to fund Henry Ford Hospital hypertension research
3. RWJF awards $1.9 million grant to PatientsLikeMe to create open research platform
4. Solid State (Smart) Transformer Market is expected to reach $5,043.39 million at a CAGR of 82.3% by 2020 - New Report by MarketsandMarkets
5. WUSTL researcher gets $2.25 million grant to better understand traumatic brain injury
6. NAS receives $3.5 million gift to establish Prize in Psychological and Cognitive Sciences
7. Dr. Lewis Cantley awarded $3 million breakthrough prize in life sciences
8. UC San Diego cancer scientist wins $3 million award
9. Flame Retardant Chemicals Market growing at a CAGR of 6.9% & to reach $7,131.9 Million by 2017 - New Report by MarketsandMarkets
10. Millions of Americans Have an STD: Report
11. Chris Guedri, of the Law Firm of Allen & Allen, Wins Case Against Food Lion and Ties for Largest Verdict in Gloucester County History: $5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... ... May 30, 2016 , ... Shaolin ... warrior 8-day-8 and 8-night special intensive summer training camp starts on June 17th ... camp offers families and children a fun and unique experience with an opportunity ...
(Date:5/29/2016)... ... May 29, 2016 , ... "With 30 unique self-animating ... user control the style of their project," said Christina Austin - CEO of Pixel ... web-themed intros created exclusively for use in Final Cut Pro X. Pixel Film Studios’ ...
(Date:5/28/2016)... ... May 28, 2016 , ... After a year and a half of planning the ... extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, 2016 ... and the United Kingdom came together to explore the many pathways individuals use to get ...
(Date:5/27/2016)... ... 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield ... (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields and ... of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and ...
(Date:5/27/2016)... ... May 27, 2016 , ... This campaign aims to provide ... we as a society can control and change. , As nearly 795,000 Americans suffering ... seconds within the United States. Plus, with an estimated 129,000 of these people dying ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... May 26, 2016 TARE ... Both Cost Savings and Overall Decreased Use ... BTG), an international specialist healthcare company, has today ... 21st Annual Meeting of ISPOR (International Society for ... hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres is ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
(Date:5/25/2016)... HILDEN , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... into a licensing and co-development agreement with Therawis Diagnostics GmbH ... project will be to develop and market PITX2 as a ... and other high-risk breast cancer patients. "We are ...
Breaking Medicine Technology: